NYSE:USNA USANA Health Sciences (USNA) Stock Forecast, Price & News $62.77 +0.87 (+1.41%) (As of 05/26/2023 08:47 PM ET) Add Compare Share Share Today's Range$61.72▼$63.2550-Day Range$60.50▼$67.9052-Week Range$48.61▼$76.58Volume42,400 shsAverage Volume70,562 shsMarket Capitalization$1.21 billionP/E Ratio18.52Dividend YieldN/APrice Target$54.50 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability USANA Health Sciences MarketRank™ ForecastAnalyst RatingHold1.50 Rating ScoreUpside/Downside13.2% Downside$54.50 Price TargetShort InterestHealthy3.18% of Float Sold ShortDividend StrengthN/ASustainability-1.89Upright™ Environmental ScoreNews Sentiment1.05Based on 4 Articles This WeekInsider TradingSelling Shares$1.61 M Sold Last QuarterProj. Earnings Growth14.75%From $3.05 to $3.50 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.85 out of 5 starsMedical Sector772nd out of 1,012 stocksMedicinals & Botanicals Industry8th out of 12 stocks 0.8 Analyst's Opinion Consensus RatingUSANA Health Sciences has received a consensus rating of Hold. The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $54.50, USANA Health Sciences has a forecasted downside of 13.2% from its current price of $62.77.Amount of Analyst CoverageUSANA Health Sciences has received no research coverage in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted3.18% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 4.9.Change versus previous monthShort interest in USANA Health Sciences has recently decreased by 11.88%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldUSANA Health Sciences does not currently pay a dividend.Dividend GrowthUSANA Health Sciences does not have a long track record of dividend growth. Previous Next 2.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreUSANA Health Sciences has received a 21.12% net impact score from Upright. The largest positive contribution comes from its "Nutrition" impact, which is driven by its "Direct selling of nutritional products through representatives", "Direct selling of dietary supplements through representatives", and "Direct selling of skincare products through representatives" products. See details.Environmental SustainabilityThe Environmental Impact score for USANA Health Sciences is -1.89. Previous Next 2.8 News and Social Media Coverage News SentimentUSANA Health Sciences has a news sentiment score of 1.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for USANA Health Sciences this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 4 people have added USANA Health Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, USANA Health Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,605,195.00 in company stock.Percentage Held by InsidersOnly 0.33% of the stock of USANA Health Sciences is held by insiders.Percentage Held by Institutions52.62% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for USANA Health Sciences are expected to grow by 14.75% in the coming year, from $3.05 to $3.50 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of USANA Health Sciences is 18.52, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 134.74.Price to Earnings Ratio vs. SectorThe P/E ratio of USANA Health Sciences is 18.52, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 133.46.Price to Book Value per Share RatioUSANA Health Sciences has a P/B Ratio of 2.66. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About USANA Health Sciences (NYSE:USNA) StockUSANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.Read More Receive USNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address USNA Stock News HeadlinesMay 27, 2023 | americanbankingnews.comStockNews.com Lowers USANA Health Sciences (NYSE:USNA) to BuyMay 25, 2023 | finance.yahoo.comUtah Company Brings Home Five Awards from Local OrganizationMay 29, 2023 | Stocks To Trade (Ad)15 A.I. Trading Opportunities a DayUsing our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.May 24, 2023 | finance.yahoo.comUSANA Executive Director honored at Utah eventMay 22, 2023 | finance.yahoo.comUSANA Releases 2022 Sustainability ReportMay 21, 2023 | americanbankingnews.comUSANA Health Sciences (NYSE:USNA) Coverage Initiated by Analysts at StockNews.comMay 12, 2023 | americanbankingnews.comUSANA Health Sciences, Inc. (NYSE:USNA) President Sells $811,188.96 in StockMay 12, 2023 | americanbankingnews.comInsider Selling: USANA Health Sciences, Inc. (NYSE:USNA) Insider Sells $180,390.24 in StockMay 29, 2023 | Stocks To Trade (Ad)15 A.I. Trading Opportunities a DayUsing our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.May 10, 2023 | americanbankingnews.comUSANA Health Sciences, Inc. (NYSE:USNA) Director John Turman Fleming Sells 1,250 SharesMay 4, 2023 | finance.yahoo.comUSANA Health Sciences Announces Plans to Expand into IndiaMay 4, 2023 | americanbankingnews.comHead-To-Head Comparison: USANA Health Sciences (NYSE:USNA) versus biote (NASDAQ:BTMD)May 3, 2023 | seekingalpha.comUSANA: China's Rebound Might Reinvigorate Growth In This StockMay 2, 2023 | finance.yahoo.comKevin Guest Shares 5 Secrets for National Recommitment Month of MayMay 1, 2023 | americanbankingnews.comUSANA Health Sciences, Inc. (NYSE:USNA) Director Frederic J. Winssinger Sells 2,000 SharesApril 30, 2023 | americanbankingnews.comUSANA Health Sciences (NYSE:USNA) Price Target Increased to $56.00 by Analysts at DA DavidsonApril 30, 2023 | americanbankingnews.comFY2023 EPS Estimates for USANA Health Sciences, Inc. Raised by Analyst (NYSE:USNA)April 29, 2023 | americanbankingnews.comUSANA Health Sciences, Inc. (NYSE:USNA) Insider David Mulham Mulham Sells 1,138 Shares of StockApril 29, 2023 | americanbankingnews.comDA Davidson Increases USANA Health Sciences (NYSE:USNA) Price Target to $56.00April 29, 2023 | americanbankingnews.comBrokers Issue Forecasts for USANA Health Sciences, Inc.'s Q2 2023 Earnings (NYSE:USNA)April 28, 2023 | americanbankingnews.comUSANA Health Sciences (NYSE:USNA) Shares Gap Up on Analyst UpgradeApril 27, 2023 | finance.yahoo.comAll You Need to Know About USANA Health (USNA) Rating Upgrade to BuyApril 27, 2023 | msn.comDA Davidson Maintains Usana Health Sciences (USNA) Neutral RecommendationApril 27, 2023 | finance.yahoo.comQ1 2023 USANA Health Sciences Inc Earnings CallApril 27, 2023 | americanbankingnews.comAkanda (NASDAQ:AKAN) versus USANA Health Sciences (NYSE:USNA) Head-To-Head ReviewApril 25, 2023 | finance.yahoo.comUSANA Health Sciences Reports First Quarter Net Sales of $248 Million and Diluted EPS of $0.95April 24, 2023 | americanbankingnews.comUSANA Health Sciences (NYSE:USNA) versus Jushi (OTCMKTS:JUSHF) Critical ContrastSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive USNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address USNA Company Calendar Last Earnings2/07/2023Today5/29/2023Next Earnings (Estimated)7/25/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Medicinals & botanicals Sub-IndustryPersonal Products SectorMedical Current SymbolNYSE:USNA CUSIP90328M10 CIK896264 Webwww.usana.com Phone(801) 954-7100Fax801-954-7300Employees1,900Year FoundedN/APrice Target and Rating Average Stock Price Forecast$54.50 High Stock Price Forecast$56.00 Low Stock Price Forecast$53.00 Forecasted Upside/Downside-13.2%Consensus RatingHold Rating Score (0-4)1.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$3.39 Trailing P/E Ratio18.52 Forward P/E Ratio20.58 P/E GrowthN/ANet Income$69.35 million Net Margins6.70% Pretax Margin10.66% Return on Equity15.31% Return on Assets11.27% Debt Debt-to-Equity RatioN/A Current Ratio3.04 Quick Ratio2.54 Sales & Book Value Annual Sales$998.60 million Price / Sales1.21 Cash Flow$4.73 per share Price / Cash Flow13.28 Book Value$23.60 per share Price / Book2.66Miscellaneous Outstanding Shares19,300,000Free Float19,234,000Market Cap$1.21 billion OptionableOptionable Beta0.78 Key ExecutivesKevin G. GuestChairman & Chief Executive OfficerJim BrownPresidentWalter NootChief Operating OfficerG. Douglas HekkingChief Financial OfficerRobert Andrew SinnottChief Scientific OfficerKey CompetitorsCronos GroupNASDAQ:CRONCanopy GrowthNASDAQ:CGCbioteNASDAQ:BTMDP3 Health PartnersNASDAQ:PIIIOPKO HealthNASDAQ:OPKView All CompetitorsInsiders & InstitutionsRoyce & Associates LPBought 2,547 shares on 5/23/2023Ownership: 0.122%Ameriprise Financial Inc.Bought 3,405 shares on 5/22/2023Ownership: 0.367%Putnam Investments LLCSold 285 shares on 5/22/2023Ownership: 0.036%JPMorgan Chase & Co.Bought 5,848 shares on 5/18/2023Ownership: 0.423%New York State Common Retirement FundSold 2,597 shares on 5/18/2023Ownership: 0.139%View All Insider TransactionsView All Institutional Transactions USNA Stock - Frequently Asked Questions Should I buy or sell USANA Health Sciences stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" USNA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in USNA, but not buy additional shares or sell existing shares. View USNA analyst ratings or view top-rated stocks. What is USANA Health Sciences' stock price forecast for 2023? 2 brokerages have issued 1-year price targets for USANA Health Sciences' stock. Their USNA share price forecasts range from $53.00 to $56.00. On average, they expect the company's stock price to reach $54.50 in the next twelve months. This suggests that the stock has a possible downside of 13.2%. View analysts price targets for USNA or view top-rated stocks among Wall Street analysts. How have USNA shares performed in 2023? USANA Health Sciences' stock was trading at $53.20 at the beginning of the year. Since then, USNA shares have increased by 18.0% and is now trading at $62.77. View the best growth stocks for 2023 here. Are investors shorting USANA Health Sciences? USANA Health Sciences saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 406,700 shares, an increase of 16.2% from the April 15th total of 350,000 shares. Based on an average daily volume of 78,700 shares, the short-interest ratio is presently 5.2 days. Currently, 3.6% of the company's shares are sold short. View USANA Health Sciences' Short Interest. When is USANA Health Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 25th 2023. View our USNA earnings forecast. How were USANA Health Sciences' earnings last quarter? USANA Health Sciences, Inc. (NYSE:USNA) posted its earnings results on Tuesday, February, 7th. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.35 by $0.31. The firm had revenue of $227.96 million for the quarter. USANA Health Sciences had a trailing twelve-month return on equity of 15.31% and a net margin of 6.70%. During the same quarter in the previous year, the company posted $1.03 earnings per share. What ETFs hold USANA Health Sciences' stock? ETFs with the largest weight of USANA Health Sciences (NYSE:USNA) stock in their portfolio include Invesco S&P SmallCap Consumer Staples ETF (PSCC), Roundhill Acquirers Deep Value ETF (DEEP), Global X Health & Wellness ETF (BFIT), Pacer US Small Cap Cash Cows 100 ETF (CALF), ETC 6 Meridian Low Beta Equity Strategy ETF (SIXL), RiverFront Dynamic US Flex-Cap ETF (RFFC), First Trust Active Factor Small Cap ETF (AFSM) and First Trust Small Cap Value AlphaDEX Fund (FYT). What guidance has USANA Health Sciences issued on next quarter's earnings? USANA Health Sciences updated its FY 2023 earnings guidance on Thursday, April, 27th. The company provided earnings per share guidance of $2.40-$3.30 for the period, compared to the consensus estimate of $2.85. The company issued revenue guidance of $875.00 million-$950.00 million, compared to the consensus revenue estimate of $935.33 million. What is Kevin Guest's approval rating as USANA Health Sciences' CEO? 68 employees have rated USANA Health Sciences Chief Executive Officer Kevin Guest on Glassdoor.com. Kevin Guest has an approval rating of 99% among the company's employees. This puts Kevin Guest in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of USANA Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other USANA Health Sciences investors own include International Business Machines (IBM), Gilead Sciences (GILD), NVIDIA (NVDA), AT&T (T), BioMarin Pharmaceutical (BMRN), Vertex Pharmaceuticals (VRTX), AbbVie (ABBV), Walt Disney (DIS), Intuitive Surgical (ISRG) and Johnson & Johnson (JNJ). What is USANA Health Sciences' stock symbol? USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA." Who are USANA Health Sciences' major shareholders? USANA Health Sciences' stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (10.04%), Renaissance Technologies LLC (6.28%), Pzena Investment Management LLC (4.24%), Dimensional Fund Advisors LP (3.11%), State Street Corp (2.22%) and Acadian Asset Management LLC (1.38%). Insiders that own company stock include Brent Neidig, Daniel A Macuga, Daniel A Macuga, David Mulham Mulham, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Gilbert A Fuller, Jim Brown, John Turman Fleming, Joshua Foukas, Kevin Guest, Myron W Wentz, Paul A Jones, Robert A Sinnott, Robert Auciaux, Timothy E Wood and Walter Noot. View institutional ownership trends. How do I buy shares of USANA Health Sciences? Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is USANA Health Sciences' stock price today? One share of USNA stock can currently be purchased for approximately $62.77. How much money does USANA Health Sciences make? USANA Health Sciences (NYSE:USNA) has a market capitalization of $1.21 billion and generates $998.60 million in revenue each year. The company earns $69.35 million in net income (profit) each year or $3.39 on an earnings per share basis. How many employees does USANA Health Sciences have? The company employs 1,900 workers across the globe. How can I contact USANA Health Sciences? USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The official website for the company is www.usana.com. The company can be reached via phone at (801) 954-7100, via email at investor.relations@usanainc.com, or via fax at 801-954-7300. This page (NYSE:USNA) was last updated on 5/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding USANA Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.